Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TheraTears Nutrition is an oral omega-3 dietary supplement developed by Advanced Vision Research for the management of dry eye syndrome. The formulation contains a specific blend of pharmaceutical-grade fish oil (providing eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA]), organically grown flaxseed oil (providing alpha-linolenic acid [ALA]), and vitamin E. It is designed to work systemically to reduce ocular surface inflammation and enhance the production of both the lipid (oil) and aqueous (water) layers of the tear film. The product has been evaluated in clinical research, including studies at the University of Waterloo's Centre for Contact Lens Research, often as part of a multi-step dry eye management protocol involving topical lubricants and eyelid hygiene products.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on TheraTears Nutrition.